Singulex, Inc. has pioneered technology that can quantitatively detect single molecules such as proteins and metabolites in complex biological samples. Our technology extends the dynamic range of any immunoassay by orders of magnitude, allowing drug developers to use biomarkers to measure drug efficacy, safety and disease progression.